Iconix Pharmaceuticals, Inc. – removing barriers to efficient drug discovery through chemogenomics

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.6, 2004-09, pp. : 741-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chemogenomics: Bridging a Drug Discovery Gap

Current Medicinal Chemistry, Vol. 9, Iss. 23, 2002-12 ,pp. : 2077-2084

Bentham Science Publishers

Access to resources Recommend Favorite

Iconix Biosciences, Inc.

By Fielden Mark R Halbert Donald N

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 401-405

Future Medicine

Access to resources Recommend Favorite

Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

By Bajorath Jürgen

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1371-1376

Informa Healthcare

Access to resources Recommend Favorite

Kinase Chemogenomics: Targeting the Human Kinome for Target Validation and Drug Discovery

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 235-253

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Computational Chemogenomics in Drug Design and Discovery)

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 17, 2012-09 ,pp. : 1867-1868

Bentham Science Publishers

Access to resources Recommend Favorite